1. Five-year survival rates for treatment-naïve patients with advanced melanoma who received ipilimumab plus darcarbazine in a phase III trial;Maio;J Clin Oncol,2015
2. Cancer Facts & Figures;American Cancer Society,2022
3. CancerProgressReport.org [Internet]. Philadelphia: American Association for Cancer Research; ©2022 [cited 2022 Nov. 02]. http://www.cancerprogressreport.org/.
4. Global burden of cutaneous melanoma in 2020 and projections to 2040;Arnold;J Am Med Assoc Dermatol,2022
5. Nitric oxide initiates progression of human melanoma via a feedback loop mediated by apurinic/apyrimidinic endonuclease-1/redox factor-1, which is inhibited by resveratrol;Yang;Mol CancerTher,2008